Search research articles
Contact Us
Filters
Showing results (381-390 of 580) with videos related to
Page
of 58
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2014
BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinoma
Christian Breunig, Bernadett J Mueller, Ludmila Umansky, et al.
Breast Cancer Research and Treatment
|
August 1, 2023
High neuroticism is associated with common late adverse effects in a nationwide sample of long-term breast cancer survivors
Alv A Dahl, Solveig K Smedsland, Kathrine F Vandraas, et al.
Pediatric Research
|
September 7, 2023
Age-related cytokine imbalance in the thymus in sudden infant death syndrome (SIDS)
Dong Qu, Vanessa Preuss, Lars Hagemeier, et al.
European Journal of Immunology
|
February 27, 2021
Influenza A virus-induced thymus atrophy differentially affects dynamics of conventional and regulatory T-cell development in mice
Yassin Elfaki, Philippe A Robert, Christoph Binz, et al.
Frontiers in Immunology
|
March 2, 2013
The Peripheral NK Cell Repertoire after Kidney Transplantation is Modulated by Different Immunosuppressive Drugs
Christine Neudoerfl, Bernadett J Mueller, Cornelia Blume, et al.
Journal of Clinical Microbiology
|
April 1, 1986
An outbreak of group B meningococcal disease: tracing the causative strain of Neisseria meningitidis by DNA fingerprinting
B E Kristiansen, B Sørensen, B Bjorvatn, et al.
Annals of Transplantation
|
August 14, 2019
Alloresponses of Mixed Lymphocyte Hepatocyte Culture to Immunosuppressive Drugs as an In-Vitro Model of Hepatocyte Transplantation
Felix Oldhafer, Eva-Maria Wittauer, Christine S Falk, et al.
International Journal of Cancer
|
August 15, 2003
Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes
Julia S Schleypen, Marion Von Geldern, Elisabeth H Weiss, et al.
Biotechnology Therapeutics
|
January 1, 1991
Results of phase I/II trials with recombinant human interleukin-3
A Ganser, O G Ottmann, G Seipelt, et al.
Behring Institute Mitteilungen
|
December 1, 1991
Preclinical and clinical evaluation of interleukin 3
A Ganser, O G Ottmann, G Seipelt, et al.
Page
of 58
Search research articles
Search
Showing results (381-390 of 580) with videos related to
Sort By:
Page
of 58
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2014
BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinoma
Christian Breunig, Bernadett J Mueller, Ludmila Umansky, et al.
Breast Cancer Research and Treatment
|
August 1, 2023
High neuroticism is associated with common late adverse effects in a nationwide sample of long-term breast cancer survivors
Alv A Dahl, Solveig K Smedsland, Kathrine F Vandraas, et al.
Pediatric Research
|
September 7, 2023
Age-related cytokine imbalance in the thymus in sudden infant death syndrome (SIDS)
Dong Qu, Vanessa Preuss, Lars Hagemeier, et al.
European Journal of Immunology
|
February 27, 2021
Influenza A virus-induced thymus atrophy differentially affects dynamics of conventional and regulatory T-cell development in mice
Yassin Elfaki, Philippe A Robert, Christoph Binz, et al.
Frontiers in Immunology
|
March 2, 2013
The Peripheral NK Cell Repertoire after Kidney Transplantation is Modulated by Different Immunosuppressive Drugs
Christine Neudoerfl, Bernadett J Mueller, Cornelia Blume, et al.
Journal of Clinical Microbiology
|
April 1, 1986
An outbreak of group B meningococcal disease: tracing the causative strain of Neisseria meningitidis by DNA fingerprinting
B E Kristiansen, B Sørensen, B Bjorvatn, et al.
Annals of Transplantation
|
August 14, 2019
Alloresponses of Mixed Lymphocyte Hepatocyte Culture to Immunosuppressive Drugs as an In-Vitro Model of Hepatocyte Transplantation
Felix Oldhafer, Eva-Maria Wittauer, Christine S Falk, et al.
International Journal of Cancer
|
August 15, 2003
Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes
Julia S Schleypen, Marion Von Geldern, Elisabeth H Weiss, et al.
Biotechnology Therapeutics
|
January 1, 1991
Results of phase I/II trials with recombinant human interleukin-3
A Ganser, O G Ottmann, G Seipelt, et al.
Behring Institute Mitteilungen
|
December 1, 1991
Preclinical and clinical evaluation of interleukin 3
A Ganser, O G Ottmann, G Seipelt, et al.
Page
of 58